AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...
AUSTIN, Texas, May 23, 2019 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its initial product, VersaWrap® Tendon Protector (VersaWrap), ...
AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...
VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding ...
AUSTIN, Texas, Sept. 16, 2024 /PRNewswire/ -- Alafair Biosciences is proud to announce that it has been selected to exhibit its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), at the Vizient ...
Alafair Biosciences, Inc., a privately held medical device company, announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement ...
AUSTIN, Texas--(BUSINESS WIRE)--Alafair Biosciences Inc., an emerging medical device company, announced today that it received 510(k) clearance from the FDA to market and sell its tendon product, ...
AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results